Browse Items (1 total)

In October 2010, the new cephalosporin, ceftaroline fosamil, was approved by the US Food and Drug Administration for therapy of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSIs). The active…
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2